NFKB1 and hepatocellular carcinoma: Given that an abnormal extracellular signal-regulated kinase (ERK) and NF-κB pathway has been implicated in tumorigenesis and therapy in HCC [19, 20], we assayed the activation of the ERK-NF-κB pathway in HCC cells following histone treatment.